Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025)
Telix Pharmaceuticals (TLX) posted quarterly Current Taxes of $30.7 million for Q4 2025, down 3.23% year-over-year from $31.8 million in Q4 2024, and down 3.23% quarter-over-quarter from $31.8 million in Q4 2024.
Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025) Analysis & Trends
Telix Pharmaceuticals (TLX) has reported Current Taxes for 3 consecutive years, with $30.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Taxes fell 3.23% year-over-year to $30.7 million; the TTM figure through Dec 2025 stood at $30.7 million (down 3.23% YoY), while the FY2025 annual figure was $30.7 million, up 2.18% from the prior year.
- Current Taxes retreated to $30.7 million in Q4 2025 per TLX's latest filing, from $31.8 million in the prior quarter.
- Across five years, Current Taxes topped out at $31.8 million in Q4 2024 and bottomed at $12.5 million in Q4 2023.
- Historically, Current Taxes has averaged $25.0 million across 3 years, with a median of $30.7 million in 2025.
- Annual changes were most pronounced in 2024 — Current Taxes surged 154.64% — and 2025, when it retreated 3.23%.
- Telix Pharmaceuticals' Current Taxes stood at $12.5 million in 2023, then soared by 154.64% to $31.8 million in 2024, then slipped by 3.23% to $30.7 million in 2025.
- Business Quant data shows TLX's Current Taxes at $30.7 million in Q4 2025, $31.8 million in Q4 2024, and $12.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Telix Pharmaceuticals | 4.00 Bn | 3.86 Bn | - | 30.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.74 Mn |
| Dec 31, 2024 | 31.77 Mn |
| Dec 31, 2023 | 12.48 Mn |